Knowledge Distillery

Multiple sclerosis and COVID‐19: how many are at risk?

In this paper, the authors pooled all consecutive patients hospitalised with laboratory-confirmed COVID-19 and acute ischaemic stroke across 28 sites…

The objective of this cross-sectional observational study was to estimate the incidence and fatality of COVID-19 and identify potential risk factors…

In this article the authors assess 88 health care workers who had received one dose of ChAdOx1 nCoV-19 vaccine 9 to 12 weeks earlier. Among these…

In this article the authors used a test-negative case–control design to estimate the effectiveness of vaccination against symptomatic disease caused…

This case-control study enrolled 58 COVID-19 positive and 62 COVID-19 negative patients, matched for age, gender and neurological admission causes,…

Risk and outcomes of COVID-19 in patients with multiple sclerosis

Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19

Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum